FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2073347 · Received May 1, 2011

Report

Report Number
2024168-2011-03055
Event Type
Injury
Date Received
May 1, 2011
Date of Event
April 1, 2011
Report Date
April 6, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY. ANGINA AND RESTENOSIS ARE KNOWN ADVERSE EVENTS AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. TWO CINE COMPACT DISCS (CDS) WERE RETURNED AND REVIEWED BY AN ABBOTT CLINICAL SPECIALIST. DURING REVIEW OF THE FIRST CD, THE CLINICAL SPECIALIST NOTED TWO DISCRETE LESIONS IN THE CALCIFIED RIGHT CORONARY ARTERY (RCA): ONE IN THE PROXIMAL VESSEL AND ONE IN THE MID VESSEL. THE LESION AREAS WERE PRE-DILATED AND TWO STENTS WERE DEPLOYED, FOLLOWED BY POST-DILATATION. THE SECOND CD SHOWED A SUB-TOTAL OCCLUSION IN THE MID-RCA (THERE IS DISTAL FLOW). THE REVIEWER CONCLUDED THAT THE IMAGES CONFIRM THAT THERE WAS A SUB-TOTAL OCCLUSION IN THE AREA OF STENTS IMPLANTED IN THE RCA. ALL STENT DELIVERY SYSTEMS ARE SUBJECTED TO A 100% VISUAL INSPECTION. IN ADDITION, A QUALITY CONTROL (Q.C.) AUDIT INSPECTION IS USED TO VERIFY THE PRODUCT QUALITY. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING. THE 3.0 X 28 MM XIENCE V IS BEING REPORTED UNDER A SEPARATE MEDWATCH REPORT NUMBER.

Description of Event or Problem · 1

IT WAS REPORTED THAT APPROXIMATELY ONE YEAR POST PLACEMENT OF TWO XIENCE V STENTS IN THE PROXIMAL RIGHT CORONARY ARTERY, THE PATIENT REPORTED CHEST PAIN. A STRESS TEST WAS POSITIVE, BUT MYOCARDIAL INFARCTION WAS RULED OUT. ON (B)(6) 2011, PER ANGIOGRAPHY, THE TWO XIENCE STENTS WERE NOTED TO BE OCCLUDED. THERE WAS NO TREATMENT PROVIDED. ON (B)(6) 2011, THE PATIENT WAS DISCHARGED IN STABLE CONDITION. ALTHOUGH REQUESTED, THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT

Patients

Seq Age Sex Outcome Treatment
1 56 YR Hospitalization| S XIENCE V 3.0 X 28 MM